The Internal Nasal Dilators Market is estimated to be valued at US$ 2.3 Bn in 2023 and is expected to exhibit a CAGR of 7.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Internal nasal dilators are devices that attach lightly inside the nose to gently widen the nasal passages and improve breathing. They are usually made of flexible polymer strips that fit inside each side of the nose to pull the walls apart slightly. This increased airflow reduces nasal resistance and makes breathing easier through the nose. Internal dilators offer a non-invasive way to improve respiratory function and comfort for those experiencing stuffed nose, snoring, or sleep apnea.
Market key trends:
Rising population adopting internal dilators for respiratory issues: There has been substantial growth in the number of people using internal nasal dilators for various respiratory conditions like snoring, sleep apnea, and nasal congestion due to environmental allergies, cold, or other factors. Many prefer them over continuous positive airway pressure (CPAP) machines for snoring and sleep apnea due to their comfortable design. This increasing adoption rate is expected to propel the internal nasal dilators market growth over the forecast period.
Porter’s Analysis
Threat of new entrants: Low capital requirements and ease of operations pose low barriers to entry in the internal nasal dilators market. However, established brands and regulatory compliances associated with medical devices provide some protection to existing players.
Bargaining power of buyers: Individual consumers have moderate bargaining power due to availability of substitutes, but hospitals and other buyers procure in bulk, giving them higher negotiating power.
Bargaining power of suppliers: Major players source raw materials like adhesives, polymers, and other compounds from specialized suppliers, placing suppliers in a strong position.
Threat of new substitutes: Some alternatives like steroid nasal sprays are substitutable but do not provide 24x7 dilation like dilators, restricting threat from substitutes.
Competitive rivalry: The presence of many regional and global players leads to high competition.
SWOT Analysis
Strengths: Non-invasive nasal dilators provide instant, drug-free relief for various respiratory conditions. They are easy to use and available without prescription.
Weaknesses: Require regular application and may not work for severe nasal obstructions. adhesive materials could irritate sensitive nasal skin.
Opportunities: Growing pollution levels and increasing incidence of allergies and sinusitis present an opportunity. Untapped regions offer scope for market expansion.
Threats: Alternate therapies like nasal strips and steroid sprays pose competition. Product recalls due to quality issues or adverse events affect brand value.
Key Takeaways
The Global Internal Nasal Dilators Market Growth is expected to witness high, exhibiting CAGR of 7.4% over the forecast period, due to increasing pollution levels, allergies and adoption of non-invasive solutions.
Regionally, North America dominates currently due to developed healthcare infrastructure and higher diagnosis rates. However, Asia Pacific is expected fastest growing region owing to rising health awareness, growing pollution, and improving access in countries like India and China.
Key players operating in the internal nasal dilators market are GlaxoSmithKline plc, Nasanita, Sanostec, Splintek, Inc., McKeon Products, Inc., Neogyn, SANOSTEC CORP, Scandinavian Formulas, Nasilator, WoodyKnows, HealthRight Products, ASO Medical, Airware Labs, Tache, Hiko Nose, RC Medical Devices, and Rhinomed. Major players are focused on product innovation and geographical expansion to bolster their position.
Read More - https://www.newsanalyticspro.com/internal-nasal-dilators-market-share-growth-analysis-size-and-forecast/
Comments
0 comment